Anna Fàbrega
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 5%
- Escherichia coli research studies
Papers in
-
- Antibiotic Resistance in Bacteria 22
- Food Science 10
- Salmonella and Campylobacter epidemiology 10
- Co-authors
- Jordi Vilà (25 shared papers)Ernest Giralt (1 shared paper)Sergio Madurga (1 shared paper)Ignasi Roca (4 shared papers)Sara Maria Soto (5 shared papers)Javier Sánchez‐Céspedes (2 shared papers)Francesc Marco (4 shared papers)Juan José González‐López (13 shared papers)
- Journals
- International Journal of Antimicrobial Agents (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)Emerging infectious diseases (3 papers)PLoS ONE (2 papers)
- Partner nations
- SpainSwitzerlandUnited States
In The Last Decade
Anna Fàbrega
40 papers receiving 2.4k citations
Anna Fàbrega's Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Medicine 798
- Endocrinology 149
- Food Science 592
- Applied Microbiology and Biotechnology 53
- Microbiology 87
Countries citing papers authored by Anna Fàbrega
This map shows the geographic impact of Anna Fàbrega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Fàbrega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Fàbrega more than expected).
Fields of papers citing papers by Anna Fàbrega
This network shows the impact of papers produced by Anna Fàbrega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Fàbrega. The network helps show where Anna Fàbrega may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Fàbrega, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Salmonella enterica Serovar Typhimurium Skills To Succeed in the Host: Virulence and Regulation Hit paper breakdown → | 2013 | 627 |
| 2 | 2008 | 379 | |
| 3 | 2013 | 167 | |
| 4 | 2011 | 154 | |
| 5 | 2011 | 119 | |
| 6 | 2008 | 106 | |
| 7 | 2019 | 91 | |
| 8 | 2011 | 80 | |
| 9 | 2006 | 71 | |
| 10 | 2017 | 69 | |
| 11 | 2010 | 58 | |
| 12 | 2018 | 54 | |
| 13 | 2014 | 50 | |
| 14 | 2009 | 45 | |
| 15 | 2009 | 43 | |
| 16 | 2015 | 41 | |
| 17 | 2023 | 30 | |
| 18 | 2011 | 29 | |
| 19 | 2020 | 29 | |
| 20 | 2021 | 28 |
About Anna Fàbrega
Anna Fàbrega is a scholar working on Molecular Medicine, Food Science, Genetics, Microbiology and Biomedical Engineering, having authored 41 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (22 papers), Salmonella and Campylobacter epidemiology (10 papers), Biosensors and Analytical Detection (5 papers), Bacterial Genetics and Biotechnology (3 papers), Bacterial biofilms and quorum sensing (2 papers), Sepsis Diagnosis and Treatment (2 papers), Yersinia bacterium, plague, ectoparasites research (2 papers) and Bacterial Infections and Vaccines (2 papers). The work is most often cited by research in Molecular Medicine (798 citations), Endocrinology (149 citations), Food Science (592 citations), Applied Microbiology and Biotechnology (53 citations) and Microbiology (87 citations). Anna Fàbrega has collaborated with scholars based in Spain, Switzerland and United States. Frequent co-authors include Jordi Vilà, Ernest Giralt, Sergio Madurga, Ignasi Roca, Sara Maria Soto, Javier Sánchez‐Céspedes, Francesc Marco, Juan José González‐López, Mar Solé and Cristina Pitart. Their work appears in journals such as International Journal of Antimicrobial Agents, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Emerging infectious diseases and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.